X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (714) 714
Newsletter (98) 98
Publication (38) 38
Book Review (18) 18
Book Chapter (11) 11
Newspaper Article (8) 8
Conference Proceeding (3) 3
Transcript (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
acromegaly (651) 651
humans (495) 495
index medicus (405) 405
endocrinology & metabolism (381) 381
female (332) 332
male (324) 324
middle aged (297) 297
adult (281) 281
medicine & public health (182) 182
diabetes (172) 172
aged (171) 171
mortality (146) 146
care and treatment (145) 145
acromegaly - drug therapy (143) 143
somatotropin (142) 142
diagnosis (140) 140
growth hormone (128) 128
endocrinology (125) 125
comorbidity (118) 118
acromegaly - complications (116) 116
growth-hormone (115) 115
research (114) 114
acromegaly - diagnosis (108) 108
somatostatin - analogs & derivatives (106) 106
insulin-like growth factor i - metabolism (104) 104
acromegaly - therapy (101) 101
somatostatin analogs (99) 99
acromegaly - epidemiology (96) 96
prevalence (96) 96
retrospective studies (93) 93
treatment outcome (92) 92
growth-factor-i (91) 91
surgery (91) 91
somatostatin - therapeutic use (83) 83
pegvisomant (82) 82
human physiology (78) 78
acromegaly - surgery (77) 77
therapy (76) 76
transsphenoidal surgery (74) 74
analysis (72) 72
epidemiology (72) 72
igf-i (72) 72
health aspects (70) 70
risk factors (70) 70
patients (69) 69
quality of life (69) 69
management (68) 68
acromegaly - blood (67) 67
follow-up (66) 66
medical research (66) 66
medicine, experimental (66) 66
octreotide (66) 66
acromegaly - metabolism (65) 65
young adult (65) 65
tumors (64) 64
internal medicine (63) 63
insulin (62) 62
hypertension (61) 61
insulin-like growth factors (61) 61
human growth hormone - blood (60) 60
pituitary (60) 60
insulin-like growth factor i (58) 58
quality-of-life (55) 55
acromegaly - physiopathology (53) 53
human growth hormone - analogs & derivatives (53) 53
pituitary-adenomas (53) 53
human growth hormone - therapeutic use (51) 51
disease (50) 50
insulin-like growth factor i - analysis (50) 50
somatostatin (50) 50
octreotide - therapeutic use (49) 49
radiotherapy (49) 49
acromegaly - etiology (48) 48
aged, 80 and over (48) 48
follow-up studies (48) 48
abridged index medicus (46) 46
growth hormones (46) 46
magnetic resonance imaging (45) 45
cross-sectional studies (44) 44
pituitary neoplasms - surgery (44) 44
diabetes mellitus (43) 43
reports (42) 42
adenoma - surgery (40) 40
adolescent (40) 40
acromegaly - pathology (39) 39
complications (39) 39
secreting pituitary-adenomas (39) 39
adenoma - complications (37) 37
consensus (37) 37
igf-1 (37) 37
physiological aspects (37) 37
pituitary adenoma (37) 37
long-term (36) 36
article (35) 35
glucose (35) 35
remission (35) 35
criteria (34) 34
human growth hormone - metabolism (34) 34
pituitary neoplasms - complications (34) 34
prognosis (34) 34
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (799) 799
Spanish (10) 10
French (8) 8
German (3) 3
Hungarian (3) 3
Polish (2) 2
Chinese (1) 1
Dutch (1) 1
Japanese (1) 1
Korean (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pituitary, ISSN 1386-341X, 8/2016, Volume 19, Issue 4, pp. 448 - 457
Journal Article
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 05/2017, Volume 176, Issue 5, p. 645
Context Acromegaly is a rare disease associated with chronic multisystem complications. National registries have been created in several countries. Design The... 
Life span | Insulin-like growth factor I | Acromegaly | Data processing | Management | Growth hormone | Disease control | Epidemiology | Cancer
Journal Article
Reviews in Endocrine and Metabolic Disorders, ISSN 1389-9155, 9/2019, Volume 20, Issue 3, pp. 365 - 381
Acromegaly is a rare chronic, systemic disorder caused by excessive growth hormone (GH) secretion from a somatotroph pituitary adenoma. GH hypersecretion leads... 
Clinical control | Medicine & Public Health | Comorbidities | Acromegaly | Internal Medicine | Biochemical control | Medical therapy | Diabetes | Endocrinology | Insulin-like growth factor I | Secretion | Insulin-like growth factors | Adenoma | Insulin | Disease control | Patients | Quality of life | Pituitary | Somatostatin | Growth hormone | Age
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 11/2016, Volume 174, Issue 11, p. 443
Objective The primary objective of this study is to identify the predictors of comorbidities and major adverse cardiovascular events (MACE) that can develop... 
Hypertension | Diabetes mellitus | Acromegaly | Remission | Somatostatin | Diabetes | Diagnosis | Patients | Smoking
Journal Article
FRONTIERS IN ENDOCRINOLOGY, ISSN 1664-2392, 03/2019, Volume 10, p. 120
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 02/2017, Volume 176, Issue 2, p. 203
Objective Acromegaly is a complex endocrine disease with multiple comorbidities. Treatment to obtain biochemical remission includes surgery, medical therapy... 
Dopamine | Comorbidity | Diabetes mellitus | Acromegaly | Population studies | Patients | Illnesses | Hypopituitarism | Pituitary | Surgery | Remission | Somatostatin | Diagnosis | Health risk assessment
Journal Article
ANNALES D ENDOCRINOLOGIE, ISSN 0003-4266, 10/2016, Volume 77, pp. S19 - S28
Acromegaly and Cushing's disease lead to common and distinct comorbidities. Currently available treatments lead to the control of hyper secretion in the... 
Acromegaly | INCREASED PREVALENCE | SLEEP-APNEA | Follow-up | HYPERCOAGULABLE STATE | Comorbidities | VERTEBRAL FRACTURES | Cushing's disease | ENDOCRINOLOGY & METABOLISM | TERM BIOCHEMICAL CONTROL | TRANSSPHENOIDAL SURGERY | QUALITY-OF-LIFE | PERSONALITY-TRAITS | GLUCOSE-TOLERANCE | CARDIOVASCULAR RISK-FACTORS
Journal Article
Neuroendocrinology, ISSN 0028-3835, 10/2006, Volume 83, Issue 3-4, pp. 249 - 257
Relief of symptoms can be achieved following surgery for growth hormone (GH)-secreting adenomas, as well as after pharmacological therapy with somatostatin... 
Reviews | Hypertension | Somatostatin analogs | Acromegaly | Arthropathy | Sleep apnea | Diabetes | Hypogonadism | TERM TREATMENT | somatostatin analogs | SLEEP-APNEA | NEUROSCIENCES | SMS 201-995 | PITUITARY-ADENOMAS | arthropathy | hypogonadism | LONG-ACTING OCTREOTIDE | THERAPY | GROWTH-HORMONE | TUMOR SHRINKAGE | ENDOCRINOLOGY & METABOLISM | LANREOTIDE AUTOGEL | acromegaly | diabetes | hypertension | sleep apnea | GLUCOSE-TOLERANCE | Pituitary Neoplasms - surgery | Carbohydrate Metabolism - drug effects | Hypogonadism - drug therapy | Adenoma - surgery | Humans | Hypertension - drug therapy | Pituitary Neoplasms - complications | Joint Diseases - complications | Hypogonadism - prevention & control | Acromegaly - complications | Joint Diseases - drug therapy | Adenoma - complications | Sleep Apnea Syndromes - drug therapy | Antineoplastic Agents, Hormonal - therapeutic use | Adenoma - drug therapy | Hypertension - prevention & control | Acromegaly - blood | Sleep Apnea Syndromes - prevention & control | Somatostatin - analogs & derivatives | Octreotide - therapeutic use | Sleep Apnea Syndromes - complications | Acromegaly - drug therapy | Adenoma - blood | Carbohydrate Metabolism - physiology | Joint Diseases - prevention & control | Pituitary Neoplasms - drug therapy | Acromegaly - surgery | Hypogonadism - complications | Hypertension - complications | Peptides, Cyclic - therapeutic use | Human Growth Hormone - blood | Pituitary Neoplasms - blood | Somatostatin - therapeutic use
Journal Article